ArticleEJNMMI research2026
Selection of SUV normalization and reference tissue for quantitative [68Ga]Ga-Pentixafor PET/CT analysis.
Article in EJNMMI research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
background[68Ga]Ga-Pentixafor PET/CT enables visualization of C-X-C chemokine receptor 4 expression, but quantitative accuracy depends on standardized uptake value (SUV) normalization and reference tissue selection. Body composition and variability across candidate organs may confound SUV interpretation.We retrospectively analyzed [68Ga]Ga-Pentixafor PET/CT scans from 40 patients without malignancy. Regions of interest were placed in the blood pool, liver, spleen, bone marrow, and muscle. Three SUV were calculated: SUV normalized by body weight (SUVbw) and SUV normalized by lean body mass (SUL), the latter derived using two methods—the conventional James formula and the Janmahasatian (Janma) formula, a revised method optimized for obese individuals. Correlations with body weight were quantified using Spearman correlation coefficients and the slope-to-intercept ratio (a/b) from linear regression analyses, while interobserver reproducibility and variability were evaluated using the intraclass correlation coefficient (ICC) and the coefficient of quartile variation (CQV), respectively. This study aimed to identify an optimal normalization strategy and reliable reference tissue for quantitative [68Ga]Ga-Pentixafor PET/CT.
resultsSUVmean, SULmean-James, and SULmean-Janma exhibited significant body-weight dependence in all candidate tissues except muscle, with the strongest association observed in the liver (right liver lobe: ρ = 0.635, 0.576, and 0.650, respectively). Compared with SUVbw, SUL derived from the James formula effectively reduced body-weight-related fluctuations in SUV measurements: a/b decreased from 0.065 to 0.034 in the right liver lobe, 0.036 to 0.021 in the left liver lobe, and 0.076 to 0.037 in the spleen. Across all normalization methods, SUV measurements demonstrated good repeatability in all candidate reference tissues (ICC > 0.7). Variability analysis showed that the liver and blood pool yielded the lowest dispersion for both SUVmean and SULmean-James (CQV: 9.4%-16.8%), identifying them as the most stable reference tissues. In contrast, splenic uptake exhibited substantial inter-individual variability (CQV: 19.9%-22.2%), suggesting it is unsuitable as a routine reference tissue.
conclusionSUL-James normalization, together with the liver or blood pool as reference tissues, provides robust and reproducible quantification for [68Ga]Ga-Pentixafor PET/CT. These findings support standardized imaging frameworks and may facilitate treatment response evaluation, prognostic assessment, and harmonization across centers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.